Literature DB >> 21632799

Follow-up and nonpharmacological management of the idiopathic pulmonary fibrosis patient.

J J Egan1.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal form of diffuse interstitial lung disease. Management of IPF requires an orderly approach, with regular evaluations and implementation of both pharmacological and nonpharmacological treatments. Pulmonary rehabilitation can relieve patients from the distressing symptoms of IPF and improve quality of life. Oxygen therapy is central to treatment of all patients. Lung transplantation enhances survival in selected patients. Mechanical ventilation may be used in patients with acute exacerbations, but the prognosis is poor in these cases. Palliative care focuses on symptom management, advance directives and end-of-life planning. Patient support groups may also play an important role.

Entities:  

Mesh:

Year:  2011        PMID: 21632799     DOI: 10.1183/09059180.00001811

Source DB:  PubMed          Journal:  Eur Respir Rev        ISSN: 0905-9180


  11 in total

1.  The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers.

Authors:  Kathleen Oare Lindell; Dio Kavalieratos; Kevin F Gibson; Laura Tycon; Margaret Rosenzweig
Journal:  Heart Lung       Date:  2016-11-18       Impact factor: 2.210

2.  [Treatment of pulmonary fibrosis. New substances and new interventions].

Authors:  U Costabel; F Bonella
Journal:  Internist (Berl)       Date:  2011-12       Impact factor: 0.743

3.  Nonpharmacological therapies for interstitial lung disease.

Authors:  Kathleen Oare Lindell
Journal:  Curr Pulmonol Rep       Date:  2018-10-18

Review 4.  Idiopathic pulmonary fibrosis: current treatment options and critical appraisal of nintedanib.

Authors:  Francesco Bonella; Susanne Stowasser; Lutz Wollin
Journal:  Drug Des Devel Ther       Date:  2015-12-14       Impact factor: 4.162

Review 5.  A Systematic Review of the Role of Dysfunctional Wound Healing in the Pathogenesis and Treatment of Idiopathic Pulmonary Fibrosis.

Authors:  Alan Betensley; Rabab Sharif; Dimitrios Karamichos
Journal:  J Clin Med       Date:  2016-12-26       Impact factor: 4.241

6.  Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study.

Authors:  Daniela Magnani; Graziana Lenoci; Sara Balduzzi; Giovanna Artioli; Paola Ferri
Journal:  Acta Biomed       Date:  2017-11-30

Review 7.  Update on therapeutic management of idiopathic pulmonary fibrosis.

Authors:  Argyris Tzouvelekis; Francesco Bonella; Paolo Spagnolo
Journal:  Ther Clin Risk Manag       Date:  2015-03-03       Impact factor: 2.423

Review 8.  Idiopathic pulmonary fibrosis: pathogenesis and management.

Authors:  Giacomo Sgalla; Bruno Iovene; Mariarosaria Calvello; Margherita Ori; Francesco Varone; Luca Richeldi
Journal:  Respir Res       Date:  2018-02-22

9.  A narrative literature review of palliative care regarding patients with idiopathic pulmonary fibrosis.

Authors:  Yasuko Igai
Journal:  Nurs Open       Date:  2018-06-03

Review 10.  Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis.

Authors:  Paloma Millan-Billi; Candela Serra; Ana Alonso Leon; Diego Castillo
Journal:  Med Sci (Basel)       Date:  2018-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.